comparemela.com
Home
Live Updates
Complement Inhibitor Naïve Paroxysmal Nocturnal Hemoglobinuria - Breaking News
Pages:
Latest Breaking News On - Complement inhibitor naïve paroxysmal nocturnal hemoglobinuria - Page 1 : comparemela.com
Iptacopan Meets Primary End Point of APPOINT-PNH Trial in Paroxysmal Nocturnal Hemoglobinuria
Iptacopan elicited improved hemoglobin levels measuring at least 2 g/dL higher vs baseline, leading to transfusion independence after 24 weeks in approximately 92.2% of patients with complement inhibitor–naïve paroxysmal nocturnal hemoglobinuria.
France general
David soergel
Antonio risitano
Giuseppe moscati
Reference center
Greater paris university hospital
Interest group
Metabolism development unit
Functional assessment
Chronic illness therapy
Hematopoietic transplant unit
Aplastic anemia
Paroxysmal nocturnal hemoglobinuria
Peffault de latour
Saint louis hospital
Complement inhibitor naïve paroxysmal nocturnal hemoglobinuria
vimarsana © 2020. All Rights Reserved.